January 2026
- Health Inequality Aversion in the United States
- Integrating Price Benchmarks and Comparative Clinical Effectiveness to Predict Initial Price Offers for Medicare Drug Price Negotiation (Initial Price Applicability Year 2027)
- Unlocking Patient Preferences: The Potential of Stated-Preference Methods in Clinical Decision Making
- Cost-Effectiveness of the 15 Drugs Selected for Initial Price Applicability Year 2027 by Centers for Medicare and Medicaid Services Drug Price Negotiation Program
- Methodological Insights From Health Valuation Studies in Low- and Middle-Income Countries: A Scoping Review
February 2026
- What Costs and Benefits Should be Counted in Health Technology Assessments and Guidelines? The NICE Perspective
- The Cost-Effectiveness of Community Health Workers in Primary Health Care: A Systematic Review
- Comparing Psychometric Properties of 6 of the 5-Level and 3-Level EQ-5D Bolt-Ons in a Large, Multinational, Longitudinal General Population Sample
- PROM-ising Progress? Trends in Patient- and Clinician-Reported Outcome Measures in US Food and Drug Administration Orphan Drug Labels
- Long-Term Outcomes and Cost-Effectiveness of Artificial Intelligence for Breast Cancer Screening: A Modeling Study
March 2026
- Disinvestment and Health Spending Efficiency in Latin America and the Caribbean: A Case Study of Colombia
- Impact of China’s National Drug Price Negotiation Policy on Availability, Affordability, and Regional Equity of Negotiated Drugs: A Multidimensional Nationwide Analysis, 2018 to 2021
- Psychometric Properties of Cognition Bolt-Ons for the EQ-5D-3L and EQ-5D-5L: A Systematic Review
- Health Utility Decrements Associated With Social Isolation and Loneliness: Evidence From Australian Longitudinal Data
- Patient-Reported Outcome Measures in Clinical Trials: An Analysis of Trends From 2008 to 2023